Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana

Vaccine

Volumn 23, Issue 8, 2005, Pages 984-995

  Saravia, N G ^a   Hazbon M H ^a   Osorio, Y ^a   Valderrama, L ^a   Walker, J ^a   Santrich, C ^b   Cortazar T ^a   LeBowitz, J H ^b   Travi, B L ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b PURDUE UNIVERSITY   (United States)

Author keywords

DNA vaccine; Leishmania; Paraflagellar rod protein

Indexed keywords

DNA VACCINE; RECOMBINANT PFR 2 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HAMSTER; IMMUNIZATION; IMMUNOGENICITY; LEISHMANIA MEXICANA; LEISHMANIASIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; CRICETINAE; FEMALE; HELA CELLS; HUMANS; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MALE; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SEX FACTORS; VACCINES, DNA;

EID: 11144296349     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.07.044     Document Type: Article

References (47)

1. S.L. Reiner, Z.E. Wang, F. Hatam, P. Scott, and R.M. Locksley Th1 and Th2 cell antigen receptors in experimental leishmaniasis Science 259 1993 1457 1460
2. E. Raz, H. Tighe, and Y. Sato Preferential induction of a TH1 inmune response and inhibition of specific IgE antibody formation by plasmid DNA immunization Proc Natl Acad Sci USA 93 1996 5141 5145
3. P.S. Walker, and Shaorton-Kersten Genetic immunization with glycoprotein 63 cDNA results in a helper T Cell type immune response and protection in a murine model of leishmaniasis Hum Gene Ther 9 13 1998 1849 1850
4. X. Damo, and F.Y. Liew Genetic vaccination against leishmaniasis Vaccine 12 1994 1534 1536
5. E.L. Segura, J. Paulone, and J.A. Cerisola Experimental Chagas' disease protective activity in relation with subcellular fractions of the parasite J Parasitol 62 1976 131 133
6. E.L. Segura, C. Vasquez, A. Bronzina, J.M. Campos, J.A. Cerisola, and S.M. Cappa Antigens of the subcellular fractions of Trypanosoma cruzi II: flagella and membrane fractions J Protozol 24 1977 540 543
7. A.M. Ruiz, M. Esteva, P. Cabeza Merkert, R.P. Laguens, and E.L. Segura Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi Acta Trop 42 1985 299 309
8. R.A. Wrightsman, M.J. Miller, J.L. Saborio, and J.E. Manning Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection Infect Immun 63 1995 122 125
9. M.J. Miller, R.A. Wrightsman, and J.E. Manning Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins in associated with a T helper type Y response Exp Parasitol 84 1996 156 167
10. M.J. Miller, R.A. Wrightsman, G.A. Striker, and J.E. Manning Protection of M-mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell but not B cell, function J Immunol 158 1997 5330 5337
11. L.L. Moore, C. Santrich, and J.H. Lebowitz Stage specific expression of the Leishmania mexicana paraflagellar rod protein PFR-2 Mol Biochem Parasitol 80 1996 125 135
12. J.A. Maga, T. Sherwin, S. Francis, K. Gull, and J.H. LeBowitz Genetic dissection of the Leishmania paraflagellar rod, a unique flagellar cytoskeleton structure J Cell Sci 112 1999 2753 2763
13. U.L. LaemmLi Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
14. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual 1989 Cold Spring Harbor Laboratory Press New York
15. R. Ismach, C.M. Cianci, J.P. Caulfield, P.J. Langer, A. Hein, and D. McMahon-Pratt Flagellar membrane and paraxial rod proteins of Leishmania: characterization employing monoclonal antibodies J Protozool 36 1989 617 624
16. "His-Bind® Kits" Technical Bulletin 054 11/99B; Novagen Inc.
17. H.A. Senekjie Studies on the culture of Leishmania tropica Trans R Soc Trop Med Hyg 33 1939 267 269
18. B.L. Travi, Y. Osorio, P.C. Melby, B. Chandrasekar, L. Arteaga, and N.G. Saravia Gender is a major determinant of the clinical evolution and immune response of hamsters infected with Leishmania viannia spp. Infect Immun 70 2002 2288 2296
19. J.E. Martinez, B.L. Travi, A.Z. Valencia, and N.G. Saravia Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters J Parasitol 77 5 1991 762 768
20. R. Zeledon, R. Soto, and G. González Experimental superimposed infection of the hamster with Leishmania mexicana and L. braziliensis Acta Trop 39 4 1982 367 372
21. I.A. Ramshaw, and A.J. Ramsay The prime-boost strategy: exciting prospects for improved vaccination Immunol Today 21 2000 16 165
22. N.L. Letvin, D.C. Montefiori, and Y. Yasutomi Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination Proc Natl Acad Sci USA 19 94 1997 9378 9383
23. M.S.H. Giannini Sex-influenced response in the pathogenesis of cutaneous leishmaniasis in mice Parasite Immunol 8 1986 31 37
24. A. Satoskar, H.H. Al-Quassi, and J. Alexander Sex-determined resistance againts Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but no male DBA/2 mice Immunol Cell Biol 76 1998 159 166
25. A. Satoskar, and J. Alexander Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expresión in DBA/2 mice infected with Leishmania mexicana Inmunology 84 1995 1 4
26. I. Sharifi, A.R. FeKri, and M.R. Aflatonian Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam Lancet 351 1998 1540 1543
27. M. Colmenares, S. Kar, K. Goldsmith-Pestana, and D. McMahon-Pratt Mechanisms of pathogenesis: differences amongst Leishmania species Trans R Soc Trop Med Hyg 96 1 2002 S3 S7
28. N. Rachamim, and C.L. Jaffe Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis J Immunol 150 1993 2322 2331
29. S.J. McSorley, D. Xu, and F.Y. Liew Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters Infect Immun 65 1997 171 178
30. S. Zimmerman, O. Egeter, and S. Hausman Cutting edge: CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis J Immunol 160 1998 3627 3630
31. D.S. Pisetsky Immune activation by bacterial DNA: a new genetic code Immunity 5 1996 303 310
32. G. Hartmann, and G.J. Weiner CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cell Proc Natl Acad Sci USA 96 16 1999 9305 9310
33. H. Hemmi, O. Takeuchi, and T. Kawai Toll-like receptor recognizes bacterial DNA Nature 408 2000 659 660
34. S. Bauer, C.J. Kirschning, and H. Hacker TLR9 confers responsiveness to bacterial DNA via species specific CpG motif recognition Proc Natl Acad Sci USA 98 2001 9237 9242
35. U.R. Hengge, E.F. Chan, R.A. Foster, P.S. Walker, and J.C. Vogel Cytokine gene expression in epidermis with biological effects following injection of naked DNA Nat Genet 10 1995 161 166
36. S. Casares, K. Inaba, T.D. Brumeanu, R.M. Steinman, and C.A. Bona Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II restricted viral epitope J Exp Med 186 1997 1481 1486
37. C.E. Kirkpatrick, T.J. Nolan, and J.P. Farrell Rate of Leishmania induced skin-lesion development in rodents depends on the site of inoculation Parasitology 94 1987 451 465
38. Y. Osorio, P. Melby, C. Pirmez, B. Chandrasekar, N. Guarín, and B.L. Travi The site of cutaneous infection influences the clinical and immunological response of hamsters infected with Leishmania panamensis Parasite Immunol 25 2003 139 148
39. G.S. Nabors, and J.P. Farrell Site-specific immunity to Leishmania in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response Infect Immun 62 1994 3655 3662
40. G.S. Nabors, T. Nolan, W. Croop, J. Li, and J.P. Farrell The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c × C57BL/6) F1 mice infected with L. major Parasite Immunol 17 1995 569 579
41. C.A. Torres, A. Iwasaki, B.H. Barber, and H.I. Robinson Differential dependence on target site tissue for gene gun and intramuscular DNA immunization J Immunol 158 1997 529 532
42. J. Charo, M. Sundback, and K. Wasserman Marked enhancement of the antigen specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drug Infect Immun 70 2002 6652 6657
43. M.A. Stanley Imiquimod and the imidazoquinolones: mechanisms of action and therapeutic potential Clin Exp Dermatol 27 2002 571 577
44. K. Loré, M.R. Betts, and J.M. Brenchley Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus and HIV-1-specific T cell responses J Immunol 171 2003 4320 4328
45. S. Rafati, A.H. Salmanian, T. Taheri, M. Vafra, and N. Fasel A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major Vaccine 19 2001 369 375
46. A. Campos-Neto, J.R. Webb, K. Greeson, R.N. Coler, Y.A. Skeiky, and S.G. Reed Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice Infect Immun 70 2002 2828 2836
47. S. Mendez, S. Gurunathan, and S. Kamhawi The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge J Immunol 166 2001 5122 5128